Upregulation of cGAS is correlated with MSI-CRC as observed in biopsies from patients with metastatic disease. Increased expression of cGAS and STING is considered an indicator of a positive immunotherapy response. Elevated levels of cGAS expression may be indicative of a better prognosis for long-term disease-free survival. This evidence concerns the gene CGAS and metastatic neoplasm.